welcome
The Motley Fool

The Motley Fool

Business

Business & Economics

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

The Motley Fool
Summary
Nutrition label

71% Informative

Catalyst Pharmaceuticals' 1.5% drop was mild compared to the S&P 500's 4.8% tumble.

Some stocks in biotech and pharmaceuticals were actually in positive territory.

The administration is gearing up to roll out a set of tariffs specifically targeting pharmaceutical exports soon.

The Motley Fool has positions in and recommends Amgen and Veeva Systems . The Motley Fool recommends AstraZeneca Plc . The Motley Fool has a disclosure policy. Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday was originally published by The Motley Fool .

VR Score

68

Informative language

66

Neutral language

21

Article tone

semi-formal

Language

English

Language complexity

51

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.